XML 52 R44.htm IDEA: XBRL DOCUMENT v3.24.3
Business Combination - Schedule of Preliminary Allocation of Consideration Transferred to the Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jan. 05, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Liabilities assumed          
Bargain purchase gain   $ 0 $ 0 $ (25,213) $ 0
Standard BioTools          
Business Acquisition [Line Items]          
Total consideration $ 444,219        
Assets acquired          
Cash and cash equivalents 278,857        
Short-term investments 148,305        
Accounts receivable 16,430        
Inventory 14,642        
Prepaid expenses and other current assets 4,835        
Property and equipment 22,455        
Non-current inventory 12,208        
Royalty receivable 4,669        
Operating lease right-of-use assets 3,796        
Other non-current assets 1,590        
Intangible Assets 25,500 $ 25,500   $ 25,500  
Total assets acquired 533,287        
Liabilities assumed          
Accounts payable and accrued liabilities 20,660        
Operating lease liabilities, current 1,601        
Deferred revenue, current 3,522        
Operating lease liabilities, non-current 2,193        
Deferred revenue, non-current 30,667        
Warrant liabilities 906        
Other non-current liabilities 4,306        
Total Liabilities 63,855        
Total fair value of net assets acquired 469,432        
Bargain purchase gain $ (25,213)